Investigator

Seattle, Washington 98109

0 studies enrolling now · 3 studies all time

What they study most

End-Stage Renal Disease (ESRD), Immune Thrombocytopenia, Immune Thrombocytopenia (ITP)

Studies at this site

• A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP) — Stopped early
• An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP) — Stopped early
• Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis — Completed